Document is current
Any future updates will be listed below
-
Authors
Norha, Jooa
Sjöros, Tanja
Garthwaite, Taru
Laine, Saara
Laitinen, Kirsi
Houttu, Noora
Vähä-Ypyä, Henri
Sievänen, Harri
Löyttyniemi, Eliisa
Vasankari, Tommi
Knuuti, Juhani
Kalliokoski, Kari K.
Heinonen, Ilkka H. A.
-
Funding
Funding for this research was provided by:
Suomen Kulttuurirahasto
Varsinais-Suomen Sairaanhoitopiiri
Turun Yliopistollisen Keskussairaalan Koulutus- ja Tutkimussäätiö
Päivikki ja Sakari Sohlbergin Säätiö (220068)
Turun Yliopistosäätiö
Research Council of Finland (324243)
Juho Vainion Säätiö
Yrjö Jahnssonin Säätiö,Finland
Diabetestutkimussäätiö
- License Information
-
More Information
Article History
Received: 13 March 2025
Accepted: 17 September 2025
First Online: 22 October 2025
Declarations
:
: The authors declare the following financial interests/personal relationships, which may be considered as potential competing interests: T.S. received a speaker fee from Pihlajalinna Plc, Tampere, Finland, and J.K. received consultancy fees from GE Healthcare and AstraZeneca and speaker fees from GE Healthcare, Bayer, Lundbeck, Boehringer-Ingelheim and Merck, outside of the submitted work. The other authors report no conflicts of interest. The results are presented clearly and honestly without fabrication, falsification, or inappropriate data manipulation.
